Vol 18, No 3 (2022)

Date published: 2022-06-27

Table of Contents

open access


Different MET gene alterations in lung adenocarcinoma patients

Paulina Terlecka, Paweł Krawczyk, Kamila Wojas-Krawczyk, Anna Grenda, Izabela Chmielewska, Robert Kieszko, Artur Bartczak, Janusz Milanowski

Research paper

DOI: 10.5603/OCP.2022.0019
Oncol Clin Pract 2022;18(3):139-146.

The rehabilitation of cancer patients and the role of nurses: a scoping review

Catarina Rodrigues, Bárbara Gomes, Carlos Albuquerque

Review paper

DOI: 10.5603/OCP.2022.0018
Oncol Clin Pract 2022;18(3):147-165.

Cisplatin — properties and clinical application

Anna Kopacz-Bednarska, Teodora Król

Review paper

DOI: 10.5603/OCP.2022.0020
Oncol Clin Pract 2022;18(3):166-176.

Evolution of prostate cancer therapy. Part 1

Paweł M. Potocki, Piotr J. Wysocki

Review paper

DOI: 10.5603/OCP.2021.0001
Oncol Clin Pract 2022;18(3):177-188.

Targeted therapy for advanced cutaneous melanoma

Alice Indini, Fausto Roila, Rossana Gueli, Francesco Grossi, Mario Mandalà

Review paper

DOI: 10.5603/OCP.2022.0005
Oncol Clin Pract 2022;18(3):197-207.

Commentary to Targeted therapy for advanced cutaneous melanoma

Piotr Rutkowski, Katarzyna Kozak


DOI: 10.5603/OCP.2022.0010
Oncol Clin Pract 2022;18(3):208-209.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl